tetrabenazine has been researched along with Hyperactivity, Motor in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (23.81) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Akbostanci, MC; Sahin, T; Yilmaz, R | 1 |
| Dashtipour, K; Koch, J; Shi, WX | 1 |
| Paton, DM | 1 |
| Armangue, T; Cantarín-Extremera, V; Duat-Rodríguez, A; González-Gutiérrez-Solana, L; López-Marín, L | 1 |
| Casaca-Carreira, J; Jahanshahi, A; Janssen, ML; Oosterloo, M; Santegoeds, RG; Temel, Y; Vlamings, R; Zeef, DH | 1 |
| Agusti, G; Bourgeois, S; Briançon, S; Fessi, H; Pailler-Mattei, C; Senta-Loys, Z | 1 |
| Jankovic, J | 2 |
| Bernardi, G; Brusa, L; Iani, C; Mercuri, NB; Moschella, V; Orlacchio, A | 1 |
| Jia, JJ; Ondo, WG | 1 |
| Guay, DR | 1 |
| Clarence-Smith, K; Jankovic, J | 1 |
| Chen, JJ; Dashtipour, K; Ondo, WG; Swope, DM | 1 |
| Davidson, A; Hunter, C; Jankovic, J; Jimenez-Shahed, J; Mehanna, R | 1 |
| LENDE, N | 1 |
| Jankovic, J; Kenney, C | 1 |
| Frucht, SJ; Greene, PE; Jain, S | 1 |
| Hunter, C; Jankovic, J; Kenney, C | 1 |
| Pakkenberg, H | 2 |
| Grahame-Smith, DG | 1 |
7 review(s) available for tetrabenazine and Hyperactivity, Motor
| Article | Year |
|---|---|
VMAT2 inhibitors for the treatment of hyperkinetic movement disorders.
Topics: Animals; Chorea; Clinical Trials as Topic; Dopamine; Humans; Huntington Disease; Hyperkinesis; Synaptic Transmission; Tardive Dyskinesia; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2020 |
Deutetrabenazine: Treatment of hyperkinetic aspects of Huntington's disease, tardive dyskinesia and Tourette syndrome.
Topics: Adrenergic Uptake Inhibitors; Animals; Drug Approval; Heart Rate; Humans; Huntington Disease; Hyperkinesis; Molecular Structure; Motor Activity; Structure-Activity Relationship; Tardive Dyskinesia; Tetrabenazine; Tourette Syndrome; Treatment Outcome; United States; United States Food and Drug Administration | 2017 |
Dopamine depleters in the treatment of hyperkinetic movement disorders.
Topics: Animals; Antipsychotic Agents; Dopamine; Dopamine Antagonists; Humans; Huntington Disease; Hyperkinesis; Movement Disorders; Receptors, Dopamine; Tardive Dyskinesia; Tetrabenazine; Tics; Treatment Outcome | 2016 |
Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Cytochrome P-450 CYP2D6; Depression; Dopamine; Drug Interactions; Genotype; Humans; Huntington Disease; Hyperkinesis; Middle Aged; Movement Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease, Secondary; Quinolizines; Reserpine; Serotonin; Tetrabenazine; Vesicular Monoamine Transport Proteins; Young Adult | 2010 |
Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.
Topics: Adrenergic Uptake Inhibitors; Chorea; Humans; Hyperkinesis; Tetrabenazine | 2011 |
Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
Topics: Adrenergic Uptake Inhibitors; Animals; Chorea; Dystonia; Humans; Huntington Disease; Hyperkinesis; Movement Disorders; Rare Diseases; Tetrabenazine; Tic Disorders | 2012 |
Tetrabenazine in the treatment of hyperkinetic movement disorders.
Topics: Adrenergic Uptake Inhibitors; Clinical Trials as Topic; Drug Tolerance; Expert Testimony; Humans; Huntington Disease; Hyperkinesis; Movement Disorders; Tetrabenazine | 2006 |
1 trial(s) available for tetrabenazine and Hyperactivity, Motor
| Article | Year |
|---|---|
Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.
Topics: Adult; Aged; Aripiprazole; Cross-Over Studies; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Huntingtin Protein; Huntington Disease; Hyperkinesis; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Piperazines; Quinolones; Receptors, Dopamine D2; Tetrabenazine; Trinucleotide Repeats | 2009 |
13 other study(ies) available for tetrabenazine and Hyperactivity, Motor
| Article | Year |
|---|---|
Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Chorea; Drug-Related Side Effects and Adverse Reactions; Dystonic Disorders; Female; Humans; Hyperkinesis; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary; Tardive Dyskinesia; Tetrabenazine; Tic Disorders; Turkey; Young Adult | 2020 |
Clinical case of anti-N-methyl-D-aspartate receptor encephalitis in an 8-month-old patient with hyperkinetic movement disorder.
Topics: Anti-Dyskinesia Agents; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Deglutition Disorders; Humans; Hyperkinesis; Immunoglobulins, Intravenous; Infant; Male; Methylprednisolone; Movement Disorders; Prednisone; Psychomotor Agitation; Stupor; Tetrabenazine; Treatment Outcome | 2013 |
An experimental model for Huntington's chorea?
Topics: Adrenergic Uptake Inhibitors; Animals; Disease Models, Animal; Huntington Disease; Hyperkinesis; Male; Rats; Rats, Transgenic; Tetrabenazine | 2014 |
Formulation of orodispersible films for paediatric therapy: investigation of feasibility and stability for tetrabenazine as drug model.
Topics: Administration, Buccal; Administration, Oral; Chemistry, Pharmaceutical; Drug Liberation; Drug Stability; Humans; Hyperkinesis; Oral Mucosal Absorption; Polymers; Saliva; Solubility; Solvents; Tetrabenazine | 2017 |
Effect of tetrabenazine use on restless legs syndrome.
Topics: Adrenergic Uptake Inhibitors; Humans; Hyperkinesis; Restless Legs Syndrome; Retrospective Studies; Tetrabenazine | 2010 |
Analysis of CYP2D6 genotype and response to tetrabenazine.
Topics: Adult; Anti-Dyskinesia Agents; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Huntington Disease; Hyperkinesis; Male; Middle Aged; Movement Disorders; Myoclonus; Pharmacogenetics; Phenotype; Psychomotor Agitation; Tetrabenazine; Tourette Syndrome; Treatment Outcome | 2013 |
Psychosedative effects of tetrabenazine (RO 1-9569) on hyperactive and disturbed mentally retarded patients.
Topics: Anesthesia; Diet, Reducing; Hyperkinesis; Hypnotics and Sedatives; Intellectual Disability; Persons with Mental Disabilities; Tetrabenazine | 1960 |
Tetrabenazine therapy of pediatric hyperkinetic movement disorders.
Topics: Adolescent; Anti-Dyskinesia Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Tolerance; Female; Follow-Up Studies; Humans; Hyperkinesis; Infant; Male; Pediatrics; Retrospective Studies; Tetrabenazine | 2006 |
Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
Topics: Adult; Age of Onset; Anti-Dyskinesia Agents; Drug Administration Schedule; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Humans; Huntington Disease; Hyperkinesis; Male; Middle Aged; Myoclonus; Parkinsonian Disorders; Prevalence; Retrospective Studies; Severity of Illness Index; Tetrabenazine; Tics; Time | 2007 |
Tetrabenazine in the treatment of hyperkinetic movement disorders.
Topics: Adolescent; Adult; Aged; Child; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Hyperkinesis; Male; Middle Aged; Movement Disorders; Myoclonus; Outcome and Process Assessment, Health Care; Syndrome; Tetrabenazine; Tourette Syndrome | 1983 |
[Nitoman treatment of hyperkinesis].
Topics: Drug Evaluation; Humans; Hyperkinesis; Tetrabenazine | 1980 |
The effect of tetrabenazine in some hyperkinetic syndromes.
Topics: Adult; Age Factors; Aged; Facial Nerve; Humans; Huntington Disease; Hyperkinesis; Mastication; Middle Aged; Parkinson Disease, Secondary; Tetrabenazine | 1968 |
Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.
Topics: 5-Hydroxytryptophan; Amines; Amino Acids; Animals; Brain Chemistry; Carboxy-Lyases; Dopamine; Fenclonine; Fever; Humans; Hyperkinesis; Male; Mixed Function Oxygenases; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Neurons; Norepinephrine; Rats; Reserpine; Serotonin; Tetrabenazine; Time Factors; Tranylcypromine; Tryptophan | 1971 |